FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

TD Armstrong

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Disorders

Mammary Neoplasms, Experimental

Physiology

Procedures

Co-author Network

Publications

TOP 3
Vivian L Weiss; Chelsea M Black; Elizabeth M Jaffee; Theodore S Kouo; Timothy H Lee; George Sgouros; Hong Song; TD Armstrong
Trafficking of high avidity HER-2/neu-specific T cells into HER-2/neu-expressing tumors after depletion of effector/memory-like regulatory T cells.
DUNG LE; Brian H Ladle; Timothy Lee; Vivian Weiss; Xiaosai Yao; Ashley Leubner; TD Armstrong; Elizabeth M Jaffee
CD8⁺ Foxp3⁺ tumor infiltrating lymphocytes accumulate in the context of an effective anti-tumor response.
Jennifer N Uram; Chelsea M Black; Emilee Flynn; LANQING HUANG; TD Armstrong; Elizabeth M Jaffee
Nondominant CD8 T cells are active players in the vaccine-induced antitumor immune response.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of TD Armstrong (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Vivian L Weiss; Chelsea M Black; Elizabeth M Jaffee; Theodore S Kouo; Timothy H Lee; George Sgouros; Hong Song; TD Armstrong
Trafficking of high avidity HER-2/neu-specific T cells into HER-2/neu-expressing tumors after depletion of effector/memory-like regulatory T cells.
PloS one 2012;7(2):e31962.
2011: DUNG LE; Brian H Ladle; Timothy Lee; Vivian Weiss; Xiaosai Yao; Ashley Leubner; TD Armstrong; Elizabeth M Jaffee
CD8⁺ Foxp3⁺ tumor infiltrating lymphocytes accumulate in the context of an effective anti-tumor response.
International journal of cancer. Journal international du cancer 2011;129(3):636-47.
2011: Jennifer N Uram; Chelsea M Black; Emilee Flynn; LANQING HUANG; TD Armstrong; Elizabeth M Jaffee
Nondominant CD8 T cells are active players in the vaccine-induced antitumor immune response.
Journal of immunology (Baltimore, Md. : 1950) 2011;186(7):3847-57.
2010: Lukas W Pfannenstiel; Samuel S K Lam; Leisha A Emens; Elizabeth M Jaffee; TD Armstrong
Paclitaxel enhances early dendritic cell maturation and function through TLR4 signaling in mice.
Cellular immunology 2010;263(1):79-87.
2008: Ihid C Leao; Priya Ganesan; TD Armstrong; Elizabeth M Jaffee
Effective depletion of regulatory T cells allows the recruitment of mesothelin-specific CD8 T cells to the antitumor immune response against a mesothelin-expressing mouse pancreatic adenocarcinoma.
Clinical and translational science 2008;1(3):228-39.
2008: Tomoharu Miyashita; Furhawn A Shah; guy marti; TD Armstrong; Jiaai Wang; Pramod Bonde; Michael K Gibson; Kiyoshi Yoshimura; Elizabeth Montgomery; Mark D Duncan; Elizabeth M Jaffee; John W Harmon
Vaccine impedes the development of reflux-induced esophageal cancer in a surgical rat model: efficacy of the vaccine in a post-Barrett's esophagus setting.
Digestive diseases and sciences 2008;53(11):2858-67.
2008: Peter S Kim; TD Armstrong; Hong Song; Matthew E Wolpoe; Vivian Weiss; Elizabeth A Manning; LANQING HUANG; Satoshi Murata; George Sgouros; Leisha A Emens; Richard T. Reilly; Elizabeth M Jaffee
Antibody association with HER-2/neu-targeted vaccine enhances CD8 T cell responses in mice through Fc-mediated activation of DCs.
The Journal of clinical investigation 2008;118(5):1700-11.
2008: Tomoharu Miyashita; Furhawn A Shah; guy marti; Jiaai Wang; TD Armstrong; Pramod Bonde; Michael K Gibson; Kiyoshi Yoshimura; Elizabeth Montgomery; Mark D Duncan; Elizabeth M Jaffee; John W Harmon
Vaccine impedes the development of reflux-induced esophageal cancer in a surgical rat model: efficacy of the vaccine in a Pre-Barrett's esophagus setting.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2008;12(1):2-7; discussion 7-9.
2007: Elizabeth A Manning; John G M Ullman; James M Leatherman; Justin M Asquith; Timothy R Hansen; TD Armstrong; Daniel J Hicklin; Elizabeth M Jaffee; Leisha A Emens
A vascular endothelial growth factor receptor-2 inhibitor enhances antitumor immunity through an immune-based mechanism.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(13):3951-9.
2006: Satoshi Murata; Brian H Ladle; Peter S Kim; Eric R Lutz; Matthew E Wolpoe; Susan E Ivie; Holly M Smith; TD Armstrong; Leisha A Emens; Elizabeth M Jaffee; Richard T. Reilly
OX40 costimulation synergizes with GM-CSF whole-cell vaccination to overcome established CD8+ T cell tolerance to an endogenous tumor antigen.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(2):974-83.
2005: Sara Gandini; Albert B Lowenfels; Elizabeth M Jaffee; TD Armstrong; Patrick Maisonneuve
Allergies and the risk of pancreatic cancer: a meta-analysis with review of epidemiology and biological mechanisms.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(8):1908-16.
2005: Anne M Ercolini; Brian H Ladle; Elizabeth A Manning; Lukas W Pfannenstiel; TD Armstrong; Jean-Pascal H Machiels; Joan G Bieler; Leisha A Emens; Richard T. Reilly; Elizabeth M Jaffee
Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response.
The Journal of experimental medicine 2005;201(10):1591-602.
2004: Amy Morck Thomas; Lynn M Santarsiero; Eric R Lutz; TD Armstrong; Yi-Cheng Chen; LANQING HUANG; Daniel Laheru; Michael Goggins; Ralph Hruban; Elizabeth M Jaffee
Mesothelin-specific CD8(+) T cell responses provide evidence of in vivo cross-priming by antigen-presenting cells in vaccinated pancreatic cancer patients.
The Journal of experimental medicine 2004;200(3):297-306.
2002: TD Armstrong; Elizabeth M Jaffee
Cytokine modified tumor vaccines.
Surgical oncology clinics of North America 2002;11(3):681-96.
1998: TD Armstrong; Virginia K Clements; Suzanne Ostrand-Rosenberg
Class II-transfected tumor cells directly present endogenous antigen to CD4+ T cells in vitro and are APCs for tumor-encoded antigens in vivo.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1998;21(3):218-24.
1998: TD Armstrong; Beth A Pulaski; Suzanne Ostrand-Rosenberg
Tumor antigen presentation: changing the rules.
Cancer immunology, immunotherapy : CII 1998;46(2):70-4.
1998: TD Armstrong; Virginia K Clements; Suzanne Ostrand-Rosenberg
MHC class II-transfected tumor cells directly present antigen to tumor-specific CD4+ T lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(2):661-6.
1998: Suzanne Ostrand-Rosenberg; Beth A Pulaski; TD Armstrong; Virginia K Clements
Immunotherapy of established tumor with MHC class II and B7.1 cell-based tumor vaccines.
Advances in experimental medicine and biology 1998;451():259-64.
1997: TD Armstrong; Virginia K Clements; B K Martin; Jenny P-Y Ting; Suzanne Ostrand-Rosenberg
Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(13):6886-91.
1992: Virginia K Clements; S Baskar; TD Armstrong; Suzanne Ostrand-Rosenberg
Invariant chain alters the malignant phenotype of MHC class II+ tumor cells.
Journal of immunology (Baltimore, Md. : 1950) 1992;149(7):2391-6.